Edition:
United States

PTC Therapeutics Inc (PTCT.O)

PTCT.O on Nasdaq

36.09USD
18 Apr 2019
Change (% chg)

$0.67 (+1.89%)
Prev Close
$35.42
Open
$35.45
Day's High
$36.28
Day's Low
$34.51
Volume
558,267
Avg. Vol
780,898
52-wk High
$52.95
52-wk Low
$25.10

About

PTC Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of medicines using its expertise in ribonucleic acid (RNA) biology. Its product pipeline includes Ataluren (Translarna), PTC596 and RG7916. Its product candidate, ataluren, is an orally administered... (more)

Overall

Beta: 1.35
Market Cap(Mil.): $812.47
Shares Outstanding(Mil.): 41.39
Dividend: --
Yield (%): --

Financials

  PTCT.O Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -3.10 -- --
ROI: -37.56 8.91 13.83
ROE: -64.70 10.06 15.25

Earnings vs. Estimates